AR101 for peanut hypersensitivity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 25 Sep 2017: Trial registered, NCT03292484
  2. 2 Nov 2017: Trial started, NCT03292484

The trials

NCT03292484: Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)

State
Completed
Phase
Phase 3
People
911 taking part
Started
2 Nov 2017
Primary completion
27 Apr 2023
Arms
AR101
Results
Posted on the registry
  1. 25 Sep 2017: Trial registered
  2. 2 Nov 2017: Trial started
  3. 27 Apr 2023: Trial completed
  4. 19 Dec 2024: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.